(4R)-4-烯丙基-1-{[(2-甲基-2-丙基)氧基]羰基}-L-脯氨酸 | 224645-82-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (4R)-4-烯丙基-1-{[(2-甲基-2-丙基)氧基]羰基}-L-脯氨酸
• 中文别名: 反-N-BOC-4-烯丙基-L-脯氨酸；氢氧化N-(羧基甲基)-N,N-二甲基-3-[(2-甲基丙烯酰)氨基]丙烷-1-铵
• 英文名称: (2S,4R)-1-(tert-butoxycarbonyl)-4-(prop-2-en-1-yl)pyrrolidine-2-carboxylic acid
• 英文别名: Boc-(R)-gamma-allyl-L-proline；(2S,4R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-4-prop-2-enylpyrrolidine-2-carboxylic acid
• CAS: 224645-82-3
• 化学式: C₁₃H₂₁NO₄
• 分子量: 255.314
• InChiKey: CYODNDBPPDGALB-ZJUUUORDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.69
• 拓扑面积：
  66.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (4R)-4-烯丙基-1-{[(2-甲基-2-丙基)氧基]羰基}-L-脯氨酸 在 4-二甲氨基吡啶 、 臭氧 、 达卡巴嗪 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 (2S,4S)-4-(2-Oxo-ethyl)-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-(2,2,2-trichloro-ethyl) ester
  参考文献：
  名称：

  焦谷氨酸衍生的双环内酰胺的立体选择性烷基化

  摘要：

  描述了衍生自焦谷氨酸的双环内酰胺的立体选择性烷基化的改进。该方法用于合成构象受限的高谷氨酸类似物。

  DOI：

  10.1016/s0040-4039(99)00345-7
• 作为产物：
  描述：

  (+)-(2R,5S,7R)-1-aza-3-oxa-2-phenyl-7-allylbicyclo<3.3.0>octan-8-one 在 lithium aluminium tetrahydride 、 水 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 (4R)-4-烯丙基-1-{[(2-甲基-2-丙基)氧基]羰基}-L-脯氨酸
  参考文献：
  名称：

  焦谷氨酸衍生的双环内酰胺的立体选择性烷基化

  摘要：

  描述了衍生自焦谷氨酸的双环内酰胺的立体选择性烷基化的改进。该方法用于合成构象受限的高谷氨酸类似物。

  DOI：

  10.1016/s0040-4039(99)00345-7

文献信息

• LINCOMYCIN DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT
  申请人：Wakiyama Yoshinari

  公开号：US20100210570A1

  公开（公告）日：2010-08-19

  An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R 1 represents N-optionally substituted C 1-6 alkyl-N-optionally substituted C 1-6 alkylamino-C 1-6 alkyl; R 2 represents a hydrogen atom or optionally substituted C 1-6 alkyl; R 3 represents optionally substituted C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目标是提供以下化合物(1)或其药理学上可接受的盐或溶剂，其中A代表芳基；R1代表N-可选取代的C1-6烷基-N-可选取代的C1-6烷基氨基-C1-6烷基；R2代表氢原子或可选取代的C1-6烷基；R3代表可选取代的C1-6烷基或C3-6环烷基-C1-4烷基；m为1至3；n为0；p为0至2。这些化合物是新颖的林可霉素衍生物，对最近在感染性疾病治疗中引起问题的耐药性肺炎链球菌具有强效活性。此外，这些化合物可用作抗微生物药物，有助于预防或治疗细菌感染性疾病。
• Lincomycin Derivatives and Antimicrobial Agents Comprising the Same as Active Ingredient
  申请人：Umemura Eijirou

  公开号：US20090156512A1

  公开（公告）日：2009-06-18

  This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R 1 represents a halide, nitro, substituted C 1-6 alkyl, optionally substituted amino, C 1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R 2 represents a hydrogen atom or C 1-6 alkyl, R 3 represents C 1-6 alkyl, all of R 4 , R 5 , and R 6 represent a hydrogen atom, R 7 represents C 1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.

  本发明提供了式（I）的化合物或其药理学上可接受的盐或溶剂，其中A代表芳基或单环或双环杂环基，R1代表卤素、硝基、取代的C1-6烷基、可选取代的氨基、C1-6烷氧羰基、可选取代的芳基、杂环基或杂环羰基，R2代表氢原子或C1-6烷基，R3代表C1-6烷基，R4、R5和R6均代表氢原子，R7代表C1-6烷基，m为1或2，n为1。这些化合物是新型的林可霉素衍生物，对耐药性肺炎球菌具有强大的活性。这些化合物可以用作抗微生物剂，并且对于预防或治疗细菌感染性疾病是有用的。
• LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
  申请人：Meiji Seika Kaisha, Ltd.

  公开号：EP1970377A1

  公开（公告）日：2008-09-17

  This invention provides compounds of formula (I) or its pharmacologically acceptable salt or solvate, wherein A represents aryl or a monocyclic or bicyclic heterocyclic group, R1 represents a halide, nitro, substituted C1-6 alkyl, optionally substituted amino, C1-6 alkyloxycarbonyl, optionally substituted aryl, a heterocyclic group, or heterocyclic carbonyl, R2 represents a hydrogen atom or C1-6 alkyl, R3 represents C1-6 alkyl, all of R4, R5, and R6 represent a hydrogen atom, R7 represents C1-6 alkyl, m is 1 or 2, and n is 1. The compounds are novel lincomycin derivatives having a potent activity against resistant pneumococci. The compounds can be used as an antimicrobial agent and are useful for preventing or treating bacterial infectious diseases.

  本发明提供了式(I)化合物或其药理学上可接受的盐或溶液，其中 A 代表芳基或单环或双环杂环基团，R1 代表卤化物、硝基、取代的 C1-6 烷基、任选取代的氨基、任选取代的 C1-6 烷氧羰基、任选取代的芳基、杂环基团或杂环羰基，R2 代表氢原子或 C1-6 烷基，R3 代表 C1-6 烷基，R4 代表 C1-6 烷基，R5 代表 C1-6 烷基、C1-6烷氧基羰基、任选取代的芳基、杂环基团或杂环羰基，R2代表氢原子或C1-6烷基，R3代表C1-6烷基，所有R4、R5和R6代表氢原子，R7代表C1-6烷基，m为1或2，n为1。这些化合物是新型的林可霉素衍生物，对耐药性肺炎球菌具有强效活性。这些化合物可用作抗菌剂，用于预防或治疗细菌性传染病。
• LINCOMYCIN DERIVATIVES AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
  申请人：Meiji Seika Kaisha Ltd.

  公开号：EP2151447A1

  公开（公告）日：2010-02-10

  An objective of the present invention is to provide compounds of formula (1) or their pharmacologically acceptable salts or solvates wherein A represents aryl; R1 represents N-optionally substituted C1-6 alkyl-N-optionally substituted C1-6 alkylamino-C1-6 alkyl; R2 represents a hydrogen atom or optionally substituted C1-6 alkyl; R3 represents optionally substituted C1-6alkyl or C3-6 cycloalkyl-C1-4 alkyl; m is 1 to 3; n is 0; and p is 0 to 2. The compounds are novel lincomycin derivatives that have a potent activity against resistant Streptococcus pneumoniae, which have recently posed problems, in the treatment of infectious diseases. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目的是提供式（1）化合物或其药理学上可接受的盐或溶液，其中 A 代表芳基；R1 代表 N-任选取代的 C1-6 烷基-N-任选取代的 C1-6 烷基氨基-C1-6 烷基；R2 代表氢原子或任选取代的 C1-6 烷基；R3 代表任选取代的 C1-6 烷基或 C3-6 环烷基-C1-4 烷基；m 为 1 至 3；n 为 0；p 为 0 至 2。这些化合物是新型的林可霉素衍生物，在治疗传染性疾病方面对耐药性肺炎链球菌有很强的活性，而耐药性肺炎链球菌近来已造成了一些问题。此外，这些化合物还可用作抗菌剂，用于预防或治疗细菌性传染病。
• Stereoselective alkylations of a bicyclic lactam derived from pyroglutamic acid
  作者：Rui Zhang、Floyd Brownewell、Jose S. Madalengoitia

  DOI：10.1016/s0040-4039(99)00345-7

  日期：1999.4

  Improvements in the stereoselective alkylation of a bicyclic lactam derived from pyroglutamic acid are described. This methodology is used to synthesize a conformationally constrained homo-glutamic acid analog.

  描述了衍生自焦谷氨酸的双环内酰胺的立体选择性烷基化的改进。该方法用于合成构象受限的高谷氨酸类似物。